PeopleBio, Inc. (KOSDAQ:304840)
South Korea · Delayed Price · Currency is KRW 1,008.00
+8.00 (0.80%)
At close: Jun 12, 2026
PeopleBio Market Cap
PeopleBio has a market cap or net worth of 24.46 billion as of June 12, 2026. Its market cap has decreased by -54.16% in one year.
Market Cap
24.46B
Enterprise Value
34.87B
Revenue
2.87B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,008.00
Market Cap Chart
Since October 19, 2020, PeopleBio's market cap has decreased from 127.63B to 24.46B, a decrease of -80.84%. That is a compound annual growth rate of -25.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 24.46B | 8.07% |
| Dec 30, 2025 | 22.63B | -64.95% |
| Dec 30, 2024 | 64.57B | -0.15% |
| Dec 28, 2023 | 64.67B | -65.14% |
| Dec 29, 2022 | 185.49B | 1.48% |
| Dec 30, 2021 | 182.78B | -36.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 222.12B |
| Cytogen | 96.78B |
| GENINUS | 94.89B |
| Inventera | 87.94B |
| GC Medical Science | 74.25B |
| HLB Panagene | 66.02B |
| Protia | 53.77B |
| Seoulin Bioscience | 45.14B |